Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies
Ray Hachem(The University of Texas MD Anderson Cancer Center), Issam Raad(Missouri Department of Agriculture), Ying Jiang(The University of Texas MD Anderson Cancer Center), Pankil Shah(Mays Cancer Center at UT Health San Antonio), Yazan Numan(Northwestern University), Andrew Assaf(The University of Texas MD Anderson Cancer Center), Anne‐Marie Chaftari(The University of Texas MD Anderson Cancer Center)
Cited by 43
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Guidelines for the Management of Intravascular Catheter-Related Infections
|Clinical Infectious Diseases|2001|1.5k
A Comparison of Two Antimicrobial-Impregnated Central Venous Catheters
|New England Journal of Medicine|1999|806
Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial
|Clinical Infectious Diseases|2006|752
Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant <i>Staphylococcus</i> Bacteremic Isolates Embedded in Biofilm
|Antimicrobial Agents and Chemotherapy|2007|347